Pascal Prigent
Directeur Général chez GENFIT
Fortune : 105 070 $ au 30/04/2024
Profil
Pascal Prigent is currently the Chief Executive Officer at Genfit SA. Previously, he held the position of Vice President & General Manager at GlaxoSmithkline SRL from 2011 to 2014, and Vice President-Marketing at GlaxoSmithKline LLC from 2014 to 2017.
Mr. Prigent obtained an MBA from INSEAD in 1995 and an undergraduate degree from NEOMA Business School in 1989.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
GENFIT SA
0,06% | 01/04/2024 | 30 708 ( 0,06% ) | 105 070 $ | 30/04/2024 |
Postes actifs de Pascal Prigent
| Sociétés | Poste | Début |
|---|---|---|
| GENFIT | Directeur Général | 16/09/2019 |
Anciens postes connus de Pascal Prigent
| Sociétés | Poste | Fin |
|---|---|---|
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Sales & Marketing | 01/11/2017 |
GlaxoSmithkline SRL
 GlaxoSmithkline SRL Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithkline SRL is a Romanian subsidiary company that operates within the pharmaceutical industry. As a part of the larger GSK Plc, GlaxoSmithkline benefits from the resources and expertise of its parent company. It is involved in the research, development, manufacturing, and marketing of a wide range of pharmaceutical products, including prescription medicines, vaccines, and consumer healthcare products. With a strong focus on innovation and improving global health, GlaxoSmithkline plays a significant role in providing healthcare solutions to people around the world. | Corporate Officer/Principal | 01/03/2014 |
Formation de Pascal Prigent
| NEOMA Business School | Undergraduate Degree |
| INSEAD | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| GENFIT | Health Technology |
| Entreprise privées | 2 |
|---|---|
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Health Technology |
GlaxoSmithkline SRL
GlaxoSmithkline SRL Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithkline SRL is a Romanian subsidiary company that operates within the pharmaceutical industry. As a part of the larger GSK Plc, GlaxoSmithkline benefits from the resources and expertise of its parent company. It is involved in the research, development, manufacturing, and marketing of a wide range of pharmaceutical products, including prescription medicines, vaccines, and consumer healthcare products. With a strong focus on innovation and improving global health, GlaxoSmithkline plays a significant role in providing healthcare solutions to people around the world. | Health Technology |